INBS Intelligent Bio Solutions Inc

$INBS 6400+ Watchers and barely 6 post in 6 days. FDA approval coming in UPtober. Let's Go. INBS Ready to lift off! 👍👌

$INBS well, can this now go to a market cap that is accaptable for a company that is selling world wide already?

$INBS The "best ever" quarter with yet the usual meager current global sales, unable to compensate for the huge losses INBS accounts for every quarter, is of no avail. It's therefore not important. The whole investment case here is the US market opportunity. And that opportunity will come only with FDA's approval. So, the first catalyst is getting that approval. Second, the market will wait for proof that INBS's product is competitive and can gain traction. Meanwhile, INBS will be incurring losses for a few more quarters in 2027 while it develops its sales network as well as prepares FDA submissions for additional indications. At some point during this second stage it will also need to raise capital. In intend to sell a half of my position on the FDA approval spike - which should be substantial given the low outstanding share count - and then wait for the inevitable capital raise before buying again in view of the profitability which will bring the successful expansion on the US market.

$INBS Its incredible. I have alerts set for this stock on a few different websites plus on their mailing list. But I still have no idea why it peaks and valleys like this at times until after everyone else heard the news and sold or bought.

$INBS what is it that we dont know? Volume stays high and price is negatively affected, I was confident about this one.

$INBS almost 40 days in red. Unreal. Management do not care a bout shareholders value at all just take our money by dillution

$INBS true garabage stock . Did a mistake in buying here. Every single day is red, very rare

$INBS every time youfthink it will not go more down it find new low. Very bad management here - they don’t care about shareholders. The first submission a year + ago was juke. How you know this? Look how much data the had to complete ti the second submission. Very weak management and the investors lost here ton of money